Mary Kay Fenton - Insider Trading & Ownership

Entity
Individual
Location
Achillion Pharmaceuticals, 300 George Street, New Haven, CT
Summary
The estimated net worth of Mary Kay Fenton is at least $1.16M dollars as of April 30, 2024. Mary Kay Fenton is the Chief Financial Officer of Talaris Therapeutics, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $1.16M.
All Insider Reports
All Insider Reports

Ownership of Mary Kay Fenton

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TRML Tourmaline Bio, Inc. Chief Financial Officer $1.16M Jul 3, 2023
CGEM Cullinan Therapeutics, Inc. Chief Financial Officer Apr 29, 2024
ONCR Oncorus, Inc. Director Jun 23, 2022

Insider Transactions Reported by Mary Kay Fenton:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.